Skip to main content

Table 3 laboratory results in the different activation status of patients with EBV-HLH

From: Clinical utility of plasma Epstein-Barr virus DNA monitoring in pediatric Epstein‐Barr virus-associated hemophagocytic lymphohistiocytosis: a Chinese retrospective observational study

 

Active

inactive

P

PBMC EBV-DNA(copies/ml)

9.15 × 105

7.04 × 104

< 0.001

Plasma EBV-DNA(copies/ml)

1.87 × 104

2.04 × 101

< 0.001

PBMC EBV-DNA in BM(copies/ml) BM(copies/ml)

5.69 × 106

3.07 × 105

0.005

Plasma EBV-DNA in BM(copies/ml) BM(copies/ml)

2.96 × 104

1.50 × 103

0.001

WBC(G/L)

3.0

4.5

0.005

HB(g/L)

90.2

100.9

< 0.001

PLT(G/L)

102.1

282.3

< 0.001

ALT(U/L)

172.3

44.0

< 0.001

AST(U/L)

292.1

40.8

< 0.001

LDH(U/L)

1598.4

330.8

< 0.001

IL-6(pg/ml)

92.1

10.7

0.001

IL-10(pg/ml)

439.0

30.3

0.001

IFN-γ(pg/ml)

319.0

30.3

0.032